Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 453 results for "pfizer"

Pfizer Given Average Rating of Buy by Analysts (NYSE:PFE)
American Banking News

US FDA approves Elelyso for injection for paediatric indicatio...

Pfizer Inc. and biopharmaceutical company, Protalix BioTherapeutics, Inc. announced that the US Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for injection for paediatric patients. Elelyso is therefore now indicated for ... PharmaBiz, 17 hours ago

351 images for pfizer

American Banking News, 2 days ago, 15 hours ago, 3 days ago
Orlando Sentinel, 4 days ago, 3 days ago, 3 days ago
Pharma Letter, 3 days ago
Pharmafocus, 3 days ago
Miami Herald, 3 days ago
Khaleej Times, 5 days ago

Market report: Astra rises on Pfizer bid talk

Traders are betting that Pfizer (NYSE: PFE - news ) will renew its interest in the FTSE 100 company In recent months investors could count on AstraZeneca (NYSE: AZN - news ) to enliven trading sessions with a touch of takeover excitement, and ...
 Yahoo! UK and Ireland1 day ago Most U.K. Stocks Advance as AstraZeneca Gains on Pfizer Report  La Repubblica1 day ago U.K. Stocks Rise as AstraZeneca Gains on Pfizer Report  BusinessWeek1 day ago U.K. Stocks Advance as AstraZeneca Gains on Pfizer Talks Report  La Repubblica1 day ago

Pfizer's C. Difficile Vaccine Gets Fast Track Status

Pfizer Inc. ( PFE ) announced that its vaccine candidate (PF-06425090) for clostridium difficile infection has been granted fast track designation by the FDA. The designation helps to expedite the development and review process of experimental drugs ...
 Yahoo! Finance1 day ago Pfizer C. diff vaccine candidate Fast Track'd  Seeking Alpha2 days ago FDA puts Pfizer's C. difficile vaccine on fast track to approval  MedCity News2 days ago Pfizers C. Difficile Vaccine Gets Fast Track Status - Analyst Blog  Big News Network9 hours ago
Bio Spectrum Asia

BMS, Pfizer to present clinical trials data on Eliquis

Singapore : The new clinical trial data and New Global Health Economics and Outcomes Research (GHEOR) analyses assessing cost effectiveness and real-world use to reinforce the alliance's commitment to the ongoing analysis of Eliquis in both the ...
 Bio Spectrum Asia1 day ago

AstraZeneca Rises as Investors Bet on Revival of Pfizer Deal

(Updates with Pfizer shares in ninth paragraph.) Aug. 29 (Bloomberg) -- AstraZeneca Plc's stock has been rising for two weeks on growing expectations the British drugmaker will re-engage in merger negotiations with Pfizer Inc. after the partial ...
 Washington Post1 day ago Investors Bet on Revival of AstraZeneca's Megadeal with Pfizer  Moneynews1 day ago Investors Bet AstraZeneca Megamerger Could Live Again  Bloomberg1 day ago

Potential Pfizer (PFE) Trade Has 4.83% Downside Protection

The patented option-trade picking algorithms that power's Artifical Intelligence Center found a trading opportunity with Pfizer Inc. ("PFE) that should provide a 3.72% ...
 Individual.com1 day ago
Bio Spectrum Asia

Pfizer seeks US FDA approval for its new drug

Singapore : Pfizer has announced that it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (US FDA) for palbociclib. This NDA requests FDA approval of palbociclib, in combination with ...
 Bio Spectrum Asia1 day ago Pfizer : Announces Submission of Palbociclib New Drug Application to the FDA  4 Traders3 days ago Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine  Pharmacy Choice3 days ago Pfizer Announces Submission of Palbociclib New Drug Application to the FDA  HispanicBusiness.com3 days ago
Globe and Mail

Time is money

Time nudges Pfizer & Astra a bit further apart Neil Unmack August 27, 2014 Last Updated at 21:31 IST A deal between Pfizer and AstraZeneca is looking a little harder following the three-month cooling-off period since takeover talks collapsed in May. Time has ...
 Business Standard3 days ago Time pushes Pfizer and Astra further apart  Globe and Mail3 days ago Pfizer weighs options on AstraZeneca bid  FirstWord Pharma6 days ago
Reuters India

Pfizer to Test Lung Cancer Drug with Immunotherapy

Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S.
 FOXBusiness.com4 days ago Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  Yahoo! Finance4 days ago Pfizer looks to Merck's experimental immunotherapy to boost outcomes for lung cancer drug  MedCity News4 days ago RPT-UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  CNBC4 days ago

Pfizer (PFE) Approaches New Upside Target of $29.15

Pfizer (NYSE:PFE) has opened bullishly above the pivot of $28.97 today and has reached the first level of resistance at $29.03. Investors may be interested in a cross of the next upside pivot targets of $29.15
 Individual.com4 days ago Pfizer (PFE) Breaks Through Resistance at $29.03  Individual.com4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
Get updated on latest news & your favorite topics right in your inbox!
More     Less